# Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention

> **NCT04937699** · PHASE4 · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 2690 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Standard-DAPT of Ticagrelor plus aspirin
- **DRUG:** Sequential monotherapy of Ticagrelor and clopidogrel

## Key facts

- **NCT ID:** NCT04937699
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-28
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 2690 (ESTIMATED)
- **Last updated:** 2024-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04937699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04937699, "Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04937699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*